Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 15Terminated 4Recruiting 3Active not recruiting 3Unknown 2Withdrawn 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 17Thoracic 9Gastrointestinal 8Genitourinary 7Head & Neck 4Sarcoma 3Tumor-Agnostic 2CNS 2Breast 2

Conditions

Neoplasms, Unknown Primary 1Neoplasm Metastasis 1

Interventions

Radiotherapy 9Drug Therapy 9Cisplatin 9Gemcitabine 8Docetaxel 7Carboplatin 7Blood Specimen Collection 7Nivolumab 6Fluorouracil 6Pemetrexed 5Capecitabine 5pembrolizumab 4Surveys and Questionnaires 4Positron Emission Tomography Computed Tomography 4Paclitaxel 4Oxaliplatin 4Exercise 4Everolimus 4Data Collection 4Cetuximab 4indibulin 3icotinib 3Vincristine 3Trastuzumab 3Standard of Care 3Radiosurgery 3Neoadjuvant Therapy 3Magnetic Resonance Spectroscopy 3Interleukin-2 3Injections 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Ipilimumab × Tumor-Agnostic × Clear all
NCT04713371 2024-05-09

A Phase 2 Trial for Patients With Metastatic Solid Cancer

Rampart Health, L.L.C.

Phase 2 Unknown
32 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT04131621 2020-04-15

CheCUP

University Hospital Heidelberg

Phase 2 Unknown
194 enrolled
Tumor-Agnostic

Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡